share_log

Viva Biotech Holdings (OTCMKTS:VBIZF) Short Interest Update

Viva Biotech Holdings (OTCMKTS:VBIZF) Short Interest Update

Viva Biotech Holdings(场外交易代码:VBIZF)空头股数更新
Defense World ·  2022/08/01 03:51

Viva Biotech Holdings (OTCMKTS:VBIZF – Get Rating) was the recipient of a large decline in short interest in July. As of July 15th, there was short interest totalling 3,330,700 shares, a decline of 26.7% from the June 30th total of 4,543,700 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

非凡生物科技控股公司(场外交易代码:VBIZF-GET Rating)是空头股数7月份股价大幅下跌的接收方。截至7月15日,空头股数共有333.07万股,较6月30日的454.37万股下降26.7%。以日均成交量0股计算,目前天数与回补比率为∞天。

Viva Biotech Stock Down 3.4 %

Viva Biotech股价下跌3.4%

OTCMKTS:VBIZF opened at $0.22 on Monday. The company has a 50 day moving average price of $0.34 and a 200-day moving average price of $0.39. Viva Biotech has a 1-year low of $0.01 and a 1-year high of $1.30.

OTCMKTS:VBIZF周一开盘报0.22美元。该公司的50日移动均线价格为0.34美元,200日移动均线价格为0.39美元。Viva Biotech的一年低点为0.01美元,一年高位为1.30美元。

Get
到达
Viva Biotech
Viva Biotech
alerts:
警报:

About Viva Biotech

关于Viva Biotech

(Get Rating)

(获取评级)

Viva Biotech Holdings, an investment holding company, provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, include protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; and antibody drug research and development services, include antigen preparation, multi-species discovery, monoclonal antibodies, antibodies functional screening and identification, antibody engineering transformation, antibody characteristics, and antibody cell line engineering transformation, as well as offers technology platforms, such as hybridoma, phage and yeast display, mammalian display, VHH antibody technology, high throughput sequencing, computer-aided drug design, HDX-MS, crystal structure determination of protein, and SPR technology.
Viva Biotech Holdings是一家投资控股公司,为全球生物技术和制药客户提供基于结构的药物发现服务。公司提供发现生物学服务,包括蛋白质表达和纯化、结构生物学、HIT发现、生物测定、生物分子相互作用和药物动力学;化学服务,如药物和合成化学、分析化学、纯化制剂、计算机辅助药物设计服务,以及提供化学技术平台;公司致力于抗体药物研发服务,包括抗原制备、多物种发现、克隆抗体、抗体功能筛选和鉴定、抗体工程转化、抗体特性和抗体细胞系工程转化,并提供杂交瘤、噬菌体和酵母展示、哺乳动物展示、VHH抗体技术、高通量测序、计算机辅助药物设计、HDX-MS、蛋白质晶体结构测定和SPR技术等技术平台。

Read More

阅读更多内容

  • Get a free copy of the StockNews.com research report on Viva Biotech (VBIZF)
  • Use These To Find Your Stock's Support and Resistance Levels
  • Is Boeing Stock is Ready for Lift-Off ?
  • Elon Musk is Out, But Should You Be In Twitter Stock?
  • 3 Earnings Announcements That Could Surprise
  • Twitter's Up For Third Week In A Row: What's Next For The Stock?
  • 免费获取StockNews.com关于Viva Biotech的研究报告(VBIZF)
  • 用这些来找出你的股票的支撑位和阻力位
  • 波音股票准备好起飞了吗?
  • 埃隆·马斯克出局了,但你应该加入推特股票吗?
  • 3个可能令人惊讶的收益公告
  • 推特连续第三周上涨:股票的下一步是什么?

Receive News & Ratings for Viva Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viva Biotech and related companies with MarketBeat.com's FREE daily email newsletter.

获得Viva Biotech Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Viva Biotech和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发